Moreover, 4-1BB protein expression showed the most elevated change between stromal and infiltrated CD8+ T cells, highlighting a possibility to utilize 4-1BB expression as a classifier for tumor immune state, and as a target for immune therapy. This evidence concerns the gene TNFRSF9 and neoplasm.